Why Clinic Success Rates Mislead

Why a clinic's headline success rate can mislead

A clinic's advertised success rate is a real number, but it answers a different question than the one most patients think. It measures the outcomes of the patients that clinic treated — not how much the clinic added to anyone's odds. Because clinics treat very different mixes of patients, two honest rates can be genuinely impossible to compare head to head.

Success reporting is not optional. Federal law — the Fertility Clinic Success Rate and Certification Act of 1992 — mandates ART success-rate reporting, and the CDC publishes it 1Ref 1Centers for Disease Control and Prevention (2024).ART Success Rates.That federal law (the Fertility Clinic Success Rate and Certification Act of 1992) mandates ART success-rate reporting and the CDC publishes it, so standardized clinic-level data is public.. So the data exists and is public, which is a real strength. But mandated reporting standardizes what is counted, not who walks through the door. That is why asking what a good success rate is puts the emphasis in the wrong place; the sharper question is 'good for whom?' The cdc art report and the SART data are where an honest reading starts, not a clinic's marketing page, and the rest of this guide is about the handful of tricks that sit between the raw data and the billboard.

The denominator game: per transfer, per retrieval, per patient

The single biggest way a success rate flatters a clinic is the denominator — the thing the percentage is divided by. The same clinic, in the same year, can report a high number or a modest one depending on whether success is counted per embryo transfer, per egg retrieval, or per patient. None of these is dishonest; they simply answer different questions — and a clinic is free to advertise whichever one flatters it most. The gap between a per-transfer number and a per-patient number, at the very same clinic in the very same year, can be large enough to reorder a list of 'top' clinics entirely.

SART reports outcomes several ways — per intended egg retrieval, per new patient, per transfer, and cumulatively — precisely because each tells a different story 2Ref 2Society for Assisted Reproductive Technology (SART) (2024).National Summary Report (SART CORS Online).That SART reports outcomes per intended egg retrieval, per new patient, per transfer, and cumulatively, and that these different denominators describe different things — including the cumulative live-birth rate across transfers from one retrieval.. A per-transfer rate excludes everyone whose cycle never reached transfer, so it tends to look best; a per-patient or cumulative figure is more honest about the whole journey. The CDC's methodology notes spell out how each measure is defined and why national figures are noncumulative 3Ref 3Centers for Disease Control and Prevention (2024).NASS Technical Notes.That the CDC's methodology defines how cycles are counted and how success measures are constructed, and explains why national ART figures are noncumulative.. Learning how to read sart success rates — knowing which denominator you are looking at — is the core defense against being misled. The cumulative live-birth rate counts births across all transfers from a single egg retrieval, and it is usually the number that actually matters to a patient.

Case mix: a clinic can look better by choosing easier patients

The deepest reason success rates mislead is case mix — the patient selection sitting behind the number. A clinic that treats younger patients with better prognoses, or declines the most difficult cases, will post higher rates without being any better at IVF. The percentage rewards who is in the pool as much as what the lab does with them.

This is not always deception; some clinics genuinely specialize. But it means comparing clinics on headline rates alone rewards selection, not skill. The moves that lift a number include cherry-picked cycles — accepting or reporting mainly favorable cases, capping who enters certain programs, or steering complex patients elsewhere. Understanding case mix patient selection is exactly why a lower-rate clinic that takes on hard cases can be excellent, while a high-rate clinic may simply pick well. When you are comparing clinics, the real question is whether their patients look anything like you. A rate built on people a decade younger than you, with a different diagnosis, is not a forecast of your odds — it is a snapshot of someone else's.

A worked example: same care, very different rate

It helps to see how identical care can produce very different headline rates. Picture two clinics with equally skilled labs and equally careful embryologists. One mainly treats patients in their early thirties with straightforward diagnoses. The other runs a program for people in their forties, for those with very low ovarian reserve, and for cancer survivors preserving fertility before treatment. Same skill, same lab, wildly different numbers.

The first clinic's headline rate will be higher, and not because its team is better. It is starting with patients who have better odds. If the second clinic wanted to 'improve' its rate, it would not need to get better at IVF at all — it could simply stop accepting the hardest cases, or report only its most favorable cycles. That is the uncomfortable core of the problem: the lever that most reliably raises a success rate is not skill, it is selection. A patient who compared these two clinics on the billboard alone would choose exactly wrong for a difficult case, sending the hard problem to the clinic least willing to take it. The only real fix is to compare within your own situation, which is what the rest of this guide is for. Two rates are only comparable when the patients behind them are comparable, and they rarely are.

Read the number inside your own age band

Age is the strongest single predictor of IVF success, so any rate that is not broken out by age is close to meaningless for an individual. A clinic's overall number blends people in their early thirties with people in their mid-forties; your odds live inside your own band, not somewhere in the average of everyone else's.

The CDC's IVF success estimator produces an individualized estimate from national data using age, height and weight, and diagnosis, for ages 20 to 50 — and it is explicitly based on national averages, not any specific clinic's results 4Ref 4Centers for Disease Control and Prevention (2024).IVF Success Estimator.That the CDC's estimator gives an individualized live-birth estimate from national data using age, height/weight, and diagnosis for ages 20-50, and is based on national averages rather than any specific clinic's results.. That distinction is the whole point: a national estimate tells you roughly what IVF does for someone like you, while a clinic's rate tells you what happened to that clinic's particular patients. Neither is a promise, but the national estimate at least holds age, weight, and diagnosis steady, which no single clinic headline does. The useful habit is to read both, and to read any clinic's numbers within your age band rather than as one blended headline figure. A clinic that publishes only a single overall number, with no age breakdown, is showing you the least informative version of its own data.

When more embryos inflate the rate — and the risk

One of the quietest ways a pregnancy rate climbs is by transferring more than one embryo at a time. It raises the odds that a given transfer produces a pregnancy, which flatters the headline number — but it also drives twins and triplets, which carry real added risk for parent and babies rather than counting as a bonus.

Elective single-embryo transfer reduces that multiple-birth risk while preserving cumulative live-birth rates, especially for younger patients and good-quality embryos 5Ref 5Practice Committees of ASRM and SART (2021).Guidance on the limits to the number of embryos to transfer: a committee opinion.That elective single-embryo transfer reduces multiple-birth risk while preserving cumulative live-birth rates, especially for younger patients and good-quality embryos — so a high multiple-birth rate offsets a high pregnancy-per-transfer rate.. So a clinic with an eye-catching pregnancy-per-transfer rate and a high multiple-birth rate may be buying its number with risk rather than skill. Single-embryo transfer can slightly lower the per-transfer headline while producing comparable cumulative results at far lower risk — which means the clinic with the slightly lower pregnancy-per-transfer rate and a very low multiple-birth rate may in fact be practising safer, more modern medicine than the one with the flashier number. A high-order multiple pregnancy is not a marketing win; it is a serious obstetric risk the headline number conveniently omits. A high pregnancy-per-transfer rate paired with a high multiple-birth rate is a warning sign, not a selling point.

Guarantees, refunds, and how selection hides inside them

Money-back guarantees and refund packages lean heavily on success rates, and they carry the same selection problem in a sharper form. A program can only afford to promise a refund if it accepts mostly good-prognosis patients — so the guarantee is often a selection tool dressed up as confidence in the lab.

Ethics guidance holds that these programs are acceptable only when success is defined in advance, all costs and exclusions are disclosed, and the clinic's own success rates are stated 6Ref 6Ethics Committee of ASRM (2023).Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion.That risk-sharing and refund programs are ethically acceptable only when success is defined in advance, all costs and exclusions are disclosed, and clinic-specific success rates are stated — and that they can carry conflicts of interest.. A clinic offering success guarantees without those conditions — a fertility clinic that guarantees success while advertising a rate it cannot substantiate — is showing you a red flag, not a reassurance. The ASRM advertising ethics standards exist for exactly this reason. Read the eligibility criteria closely: if only the easiest cases qualify, the 'guarantee' is telling you about the selection, not the skill. The people most likely to be turned away from a refund program are precisely the ones for whom a refund would matter most.

How to actually read clinic success data

Reading clinic data well is a learnable habit, and it starts with going to the source instead of the billboard. The federally mandated SART and CDC datasets let you compare clinics on standardized terms, and the skill is to control for the things a single headline rate is designed to hide. A short discipline covers most of it:

• Go to the sart success-rate data and the CDC report, not a clinic's marketing page.
• Read within your age band, and prefer per-intended-retrieval and cumulative live-birth numbers over per-transfer rates.
• Look at the singleton live-birth rate and the multiple-birth rate together; a high twin rate offsets an impressive pregnancy rate.
• Check whether the clinic's patients resemble you, because case mix patient selection is the whole game when comparing clinics.
• Bring first-consult questions. Asking at your first fertility consult how the clinic defines success, and how its patients compare with you, turns a number into a conversation.
• Watch the cancellation rate. A clinic can lift its per-transfer rate by cancelling cycles that respond poorly before they ever reach transfer, so ask how often cycles are cancelled and where those patients land in the statistics.

When you research a fertility clinic near you, the goal is never the single highest number. It is the clinic whose real results — for patients who actually look like you — still hold up once these questions are asked. A number that survives that scrutiny means something; a number on a billboard, by itself, does not.